The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
72
2 inhalations as a single dose
2 inhalations as a single dose
2 inhalations as a single dose
Orion Pharma Clinical Pharmacology Unit
Espoo, Finland
Pharmacokinetic parameter Cmax of plasma budesonide concentration
Time frame: within 12 h
Pharmacokinetic parameter Cmax of plasma formoterol concentration
Time frame: within 24 h
Pharmacokinetic parameter AUCt of plasma budesonide concentration
Time frame: Within 12 h
Pharmacokinetic parameter AUCt of plasma formoterol concentration
Time frame: Within 24 h
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
2 inhalations as a single dose